Urogenit Tract Infect.  2024 Aug;19(2):44-47. 10.14777/uti.2024.19.2.44.

Hyperbaric Oxygen Therapy for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Case Report

Affiliations
  • 1Departments of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea
  • 2Departments of Emergency Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
  • 3Departments of Medical Informatics and Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Korea
  • 4Center of Evidence-Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, Korea

Abstract

Hyperbaric oxygen therapy (HBOT) was conducted on two male patients with chronic prostatitis/chronic pelvic pain syndrome who were resistant to conventional medical therapies. Both patients underwent 20 sessions of 100% oxygen inhalation (2.0 atmosphere absolute for 90 min/day, five days/week for four weeks) in a hyperbaric chamber. The follow-up period was three months. Although the patients reported a slight improvement in the pain domain of the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) after HBOT, no changes were noted in the other domains of NIH-CPSI and International Prostate Symptom Score. No adverse events were encountered during or after HBOT.

Keyword

Hyperbaric oxygenation; Prostatitis
Full Text Links
  • UTI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr